AGP Executive Report
Last update: 7 hours agoHemp Policy Fight: Montana hemp processors say a U.S. Senate delay on a planned hemp ban is a “huge win,” buying time after concerns about potent hemp products reaching kids. Public Health & Safety: A pediatrician/ neuroscientist op-ed argues Congress must close the “intoxicating hemp” loophole for delta-8-style products sold like candy, pushing for stronger oversight and age protections. Clinical Research: A new clinical trial report claims oral CBD can ease post-surgery ocular pain as effectively as opioids. Market & Regulation: Texas THC product rules remain in flux as lawsuits and enforcement actions keep reshaping what’s on shelves. Criminal Justice: China prosecutors say two foreign transit passengers pleaded guilty after being caught with 70 kg of cannabis at Beijing airport, despite “in transit” claims. Industry Expansion: Argent BioPharma is pushing into the U.S. with medicinal cannabis therapy for dogs with cancer. Community & Care: A Massachusetts crackdown on kratom continues with emergency orders targeting products.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
